DOTA-JR11
DOTA-JR11 is a SSTR2-targeting antagonist for research use, capable of being radiolabeled with 68Ga. It enables paired PET imaging in neuroendocrine tumor (NET) studies, facilitating both in vitro receptor binding assays and in vivo tumor visualization in preclinical models.
Product Specifications
Field of Research
Pharmacology & Drug Discovery
Molecular Weight
1689.27
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog